世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 世界および日本のヒト免疫グロブリン（pH4）静注用市場の洞察、2027年までの予測Global and Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Insights, Forecast to 2027 正常なヒトの血漿から低温エタノール法で分離・抽出し、さらに処理やウイルス不活化の工程を経て精製された免疫グロブリンの組み合わせです。本製品は、完全な未修飾の天然lgG抗体であり、純度は最大98%です。防... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー正常なヒトの血漿から低温エタノール法で分離・抽出し、さらに処理やウイルス不活化の工程を経て精製された免疫グロブリンの組み合わせです。本製品は、完全な未修飾の天然lgG抗体であり、純度は最大98%です。防腐剤や抗生物質を含まず、点滴用に開発されたものです。筋肉内ガンマグロブリンと比較して、即効性があり、効果が大きいのが利点です。市場分析とインサイト世界および日本のヒト免疫グロブリン(pH4)静注用市場 本レポートでは、世界と日本の静注用ヒト免疫グロブリン(pH4)市場に焦点を当てています。 2020年の世界のHuman Immunoglobulin(pH4)for Intravenous Injection市場規模はXX百万米ドルで、2021-2027年の間にXX％のCAGRで2027年末にはXX百万米ドルに達すると予想されています。日本では、Human Immunoglobulin(pH4)for Intravenous Injectionの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。 世界のヒト免疫グロブリン(pH4)静注用の範囲と市場規模 静脈注射用ヒト免疫グロブリン(pH4)市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のHuman Immunoglobulin(pH4)for Intravenous Injection市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。 日本市場では、2016-2027年の期間で、プレーヤー別、タイプ別、アプリケーション別の静脈注射用ヒト免疫グロブリン(pH4)の市場規模に焦点を当てています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。 タイプ別セグメント 1g/20ml 1.25g/25ml 2.5g/50ml 5g/100ml 10g/200ml 用途別セグメント 病院 クリニック その他 地域別 北アメリカ アメリカ カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア UAE 会社別 ボヤ-バイオ 北京天壇生物製品 花蘭咲バイオ Guangdong Shuagnlin Bio-pharmacy 威光生物 シノファーム 上海RAAS CTBB 南越バイオファーミング 目次1 Study Coverage1.1 Human Immunoglobulin(pH4) for Intravenous Injection Product Introduction 1.2 Market by Type 1.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Growth Rate by Type 1.2.2 1g/20ml 1.2.3 1.25g/25ml 1.2.4 2.5g/50ml 1.2.5 5g/100ml 1.2.6 10g/200ml 1.3 Market by Application 1.3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size, Estimates and Forecasts 2.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue 2016-2027 2.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales 2016-2027 2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Human Immunoglobulin(pH4) for Intravenous Injection Historical Market Size by Region (2016-2021) 2.3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Region (2022-2027) 2.4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Region (2022-2027) 3 Global Human Immunoglobulin(pH4) for Intravenous Injection Competitor Landscape by Players 3.1 Global Top Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers by Sales 3.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Manufacturer (2016-2021) 3.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers by Revenue 3.2.1 Key Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers Covered: Ranking by Revenue 3.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Manufacturers (2016-2021) 3.2.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Human Immunoglobulin(pH4) for Intravenous Injection Revenue in 2020 3.2.6 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Manufacturers 3.4 Global Human Immunoglobulin(pH4) for Intravenous Injection Manufacturing Base Distribution, Product Types 3.4.1 Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Human Immunoglobulin(pH4) for Intravenous Injection Product Type 3.4.3 Date of International Manufacturers Enter into Human Immunoglobulin(pH4) for Intravenous Injection Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Type (2016-2021) 4.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021) 4.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type (2016-2021) 4.1.3 Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Forecast by Type (2022-2027) 4.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Type (2022-2027) 4.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Type (2022-2027) 4.2.3 Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Application (2016-2021) 5.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021) 5.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application (2016-2021) 5.1.3 Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2021) 5.2 Human Immunoglobulin(pH4) for Intravenous Injection Market Size Forecast by Application (2022-2027) 5.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Application (2022-2027) 5.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Application (2022-2027) 5.2.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 6.1.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales YoY Growth 2016-2027 6.1.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue YoY Growth 2016-2027 6.1.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Share in Global Market 2016-2027 6.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Players (International and Local Players) 6.2.1 Japan Top Human Immunoglobulin(pH4) for Intravenous Injection Players by Sales (2016-2021) 6.2.2 Japan Top Human Immunoglobulin(pH4) for Intravenous Injection Players by Revenue (2016-2021) 6.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Historic Market Review by Type (2016-2021) 6.3.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2021) 6.3.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Type (2016-2021) 6.3.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2016-2021) 6.4 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Type (2022-2027) 6.4.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Type (2022-2027) 6.4.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Type (2022-2027) 6.5 Japan Human Immunoglobulin(pH4) for Intravenous Injection Historic Market Review by Application (2016-2021) 6.5.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2021) 6.5.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Application (2016-2021) 6.5.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2021) 6.6 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Application (2022-2027) 6.6.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Application (2022-2027) 6.6.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Application (2022-2027) 7 North America 7.1 North America Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 7.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 7.2.1 North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 7.2.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 8.2 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Region 8.2.1 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Region (2016-2021) 8.2.2 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 9.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 9.2.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 9.2.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 10.2 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 10.2.1 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 10.2.2 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 11.2.1 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 11.2.2 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Boya-Bio 12.1.1 Boya-Bio Corporation Information 12.1.2 Boya-Bio Description and Business Overview 12.1.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.1.5 Boya-Bio Recent Development 12.2 Beijing Tiantan Biological Products 12.2.1 Beijing Tiantan Biological Products Corporation Information 12.2.2 Beijing Tiantan Biological Products Description and Business Overview 12.2.3 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.2.5 Beijing Tiantan Biological Products Recent Development 12.3 Hualan Bio 12.3.1 Hualan Bio Corporation Information 12.3.2 Hualan Bio Description and Business Overview 12.3.3 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.3.5 Hualan Bio Recent Development 12.4 Guangdong Shuagnlin Bio-pharmacy 12.4.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information 12.4.2 Guangdong Shuagnlin Bio-pharmacy Description and Business Overview 12.4.3 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Development 12.5 Weiguang Biological 12.5.1 Weiguang Biological Corporation Information 12.5.2 Weiguang Biological Description and Business Overview 12.5.3 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.5.5 Weiguang Biological Recent Development 12.6 Sinopharm 12.6.1 Sinopharm Corporation Information 12.6.2 Sinopharm Description and Business Overview 12.6.3 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.6.5 Sinopharm Recent Development 12.7 Shanghai RAAS 12.7.1 Shanghai RAAS Corporation Information 12.7.2 Shanghai RAAS Description and Business Overview 12.7.3 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.7.5 Shanghai RAAS Recent Development 12.8 CTBB 12.8.1 CTBB Corporation Information 12.8.2 CTBB Description and Business Overview 12.8.3 CTBB Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.8.4 CTBB Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.8.5 CTBB Recent Development 12.9 Nanyue Biopharming 12.9.1 Nanyue Biopharming Corporation Information 12.9.2 Nanyue Biopharming Description and Business Overview 12.9.3 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.9.5 Nanyue Biopharming Recent Development 12.11 Boya-Bio 12.11.1 Boya-Bio Corporation Information 12.11.2 Boya-Bio Description and Business Overview 12.11.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.11.5 Boya-Bio Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Human Immunoglobulin(pH4) for Intravenous Injection Industry Trends 13.2 Human Immunoglobulin(pH4) for Intravenous Injection Market Drivers 13.3 Human Immunoglobulin(pH4) for Intravenous Injection Market Challenges 13.4 Human Immunoglobulin(pH4) for Intravenous Injection Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Human Immunoglobulin(pH4) for Intravenous Injection Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
SummaryThe immunoglobulin combination was separated and extracted from normal human plasma by the low-temperature ethanol method, and refined through further processing and virus inactivation steps. This product is a complete, unmodified natural lgG antibody with a purity of up to 98%. It contains no preservatives and antibiotics and is intended for intravenous infusion. Compared with intramuscular gamma globulin, it has a faster effect and a significant effect. advantage. Table of Contents1 Study Coverage1.1 Human Immunoglobulin(pH4) for Intravenous Injection Product Introduction 1.2 Market by Type 1.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Growth Rate by Type 1.2.2 1g/20ml 1.2.3 1.25g/25ml 1.2.4 2.5g/50ml 1.2.5 5g/100ml 1.2.6 10g/200ml 1.3 Market by Application 1.3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size, Estimates and Forecasts 2.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue 2016-2027 2.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales 2016-2027 2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Human Immunoglobulin(pH4) for Intravenous Injection Historical Market Size by Region (2016-2021) 2.3.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Region (2022-2027) 2.4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Region (2022-2027) 3 Global Human Immunoglobulin(pH4) for Intravenous Injection Competitor Landscape by Players 3.1 Global Top Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers by Sales 3.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Manufacturer (2016-2021) 3.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers by Revenue 3.2.1 Key Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers Covered: Ranking by Revenue 3.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Manufacturers (2016-2021) 3.2.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Human Immunoglobulin(pH4) for Intravenous Injection Revenue in 2020 3.2.6 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price by Manufacturers 3.4 Global Human Immunoglobulin(pH4) for Intravenous Injection Manufacturing Base Distribution, Product Types 3.4.1 Human Immunoglobulin(pH4) for Intravenous Injection Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Human Immunoglobulin(pH4) for Intravenous Injection Product Type 3.4.3 Date of International Manufacturers Enter into Human Immunoglobulin(pH4) for Intravenous Injection Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Type (2016-2021) 4.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Type (2016-2021) 4.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Type (2016-2021) 4.1.3 Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size Forecast by Type (2022-2027) 4.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Type (2022-2027) 4.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Type (2022-2027) 4.2.3 Human Immunoglobulin(pH4) for Intravenous Injection Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Application (2016-2021) 5.1.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales by Application (2016-2021) 5.1.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Application (2016-2021) 5.1.3 Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2021) 5.2 Human Immunoglobulin(pH4) for Intravenous Injection Market Size Forecast by Application (2022-2027) 5.2.1 Global Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Application (2022-2027) 5.2.2 Global Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Application (2022-2027) 5.2.3 Global Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 6.1.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales YoY Growth 2016-2027 6.1.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue YoY Growth 2016-2027 6.1.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Share in Global Market 2016-2027 6.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Size by Players (International and Local Players) 6.2.1 Japan Top Human Immunoglobulin(pH4) for Intravenous Injection Players by Sales (2016-2021) 6.2.2 Japan Top Human Immunoglobulin(pH4) for Intravenous Injection Players by Revenue (2016-2021) 6.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Historic Market Review by Type (2016-2021) 6.3.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Type (2016-2021) 6.3.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Type (2016-2021) 6.3.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price by Type (2016-2021) 6.4 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Type (2022-2027) 6.4.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Type (2022-2027) 6.4.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Type (2022-2027) 6.5 Japan Human Immunoglobulin(pH4) for Intravenous Injection Historic Market Review by Application (2016-2021) 6.5.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Market Share by Application (2016-2021) 6.5.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Market Share by Application (2016-2021) 6.5.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price by Application (2016-2021) 6.6 Japan Human Immunoglobulin(pH4) for Intravenous Injection Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Human Immunoglobulin(pH4) for Intravenous Injection Sales Forecast by Application (2022-2027) 6.6.2 Japan Human Immunoglobulin(pH4) for Intravenous Injection Revenue Forecast by Application (2022-2027) 6.6.3 Japan Human Immunoglobulin(pH4) for Intravenous Injection Price Forecast by Application (2022-2027) 7 North America 7.1 North America Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 7.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 7.2.1 North America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 7.2.2 North America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 8.2 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Region 8.2.1 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Sales by Region (2016-2021) 8.2.2 Asia Pacific Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 9.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 9.2.1 Europe Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 9.2.2 Europe Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 10.2 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 10.2.1 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 10.2.2 Latin America Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Market Facts & Figures by Country 11.2.1 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Sales by Country (2016-2021) 11.2.2 Middle East and Africa Human Immunoglobulin(pH4) for Intravenous Injection Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Boya-Bio 12.1.1 Boya-Bio Corporation Information 12.1.2 Boya-Bio Description and Business Overview 12.1.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.1.5 Boya-Bio Recent Development 12.2 Beijing Tiantan Biological Products 12.2.1 Beijing Tiantan Biological Products Corporation Information 12.2.2 Beijing Tiantan Biological Products Description and Business Overview 12.2.3 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Beijing Tiantan Biological Products Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.2.5 Beijing Tiantan Biological Products Recent Development 12.3 Hualan Bio 12.3.1 Hualan Bio Corporation Information 12.3.2 Hualan Bio Description and Business Overview 12.3.3 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Hualan Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.3.5 Hualan Bio Recent Development 12.4 Guangdong Shuagnlin Bio-pharmacy 12.4.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information 12.4.2 Guangdong Shuagnlin Bio-pharmacy Description and Business Overview 12.4.3 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Guangdong Shuagnlin Bio-pharmacy Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.4.5 Guangdong Shuagnlin Bio-pharmacy Recent Development 12.5 Weiguang Biological 12.5.1 Weiguang Biological Corporation Information 12.5.2 Weiguang Biological Description and Business Overview 12.5.3 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Weiguang Biological Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.5.5 Weiguang Biological Recent Development 12.6 Sinopharm 12.6.1 Sinopharm Corporation Information 12.6.2 Sinopharm Description and Business Overview 12.6.3 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Sinopharm Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.6.5 Sinopharm Recent Development 12.7 Shanghai RAAS 12.7.1 Shanghai RAAS Corporation Information 12.7.2 Shanghai RAAS Description and Business Overview 12.7.3 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Shanghai RAAS Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.7.5 Shanghai RAAS Recent Development 12.8 CTBB 12.8.1 CTBB Corporation Information 12.8.2 CTBB Description and Business Overview 12.8.3 CTBB Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.8.4 CTBB Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.8.5 CTBB Recent Development 12.9 Nanyue Biopharming 12.9.1 Nanyue Biopharming Corporation Information 12.9.2 Nanyue Biopharming Description and Business Overview 12.9.3 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Nanyue Biopharming Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.9.5 Nanyue Biopharming Recent Development 12.11 Boya-Bio 12.11.1 Boya-Bio Corporation Information 12.11.2 Boya-Bio Description and Business Overview 12.11.3 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Boya-Bio Human Immunoglobulin(pH4) for Intravenous Injection Products Offered 12.11.5 Boya-Bio Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Human Immunoglobulin(pH4) for Intravenous Injection Industry Trends 13.2 Human Immunoglobulin(pH4) for Intravenous Injection Market Drivers 13.3 Human Immunoglobulin(pH4) for Intravenous Injection Market Challenges 13.4 Human Immunoglobulin(pH4) for Intravenous Injection Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Human Immunoglobulin(pH4) for Intravenous Injection Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD（injection）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
